Pay in 4 interest-free payments of $5.63 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
ReCePI is powered on an expected 30% incidence of AKI in high-risk complex cardiac surgery subjects based on the incidence of renal impairment in two prior studies performed by the Sponsor [8, 24]
Sesso HD, Gaziano JM, Liu S, Buring JE
Treating human autoimmunity: current practice and future prospects
Additional information Journal peer review information: Nature Communications thanks the anonymous reviewers for their contribution to the peer review of this work
Individuals who wish to take care of their nervous system, especially people under stress, anxiety or elderly people.
Inhibition of SARS-CoV-2 entry through the ACE2/TMPRSS2 pathway: a promising approach for uncovering early COVID-19 drug therapies
US$ 20.14
US$ 29.15
US$ 24.59
US$ 29.02
